Keros Therapeutics
KROS
KROS
165 hedge funds and large institutions have $409M invested in Keros Therapeutics in 2025 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 39 increasing their positions, 73 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $559M → $409M (-$150M)
47% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 73
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
165
Holding in Top 10
1
Calls
$10.4M
Puts
$4.54M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$8.44M | |
| 3 | +$7.67M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.2M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$4.46M |
Top Sellers
| 1 | -$94.2M | |
| 2 | -$34.6M | |
| 3 | -$33.1M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$22.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.9M |
